Table 2.
Baseline population characteristics of 378 patients with raised blood biomarker result undergoing TE
| Variable | All patients undergoing TE (n=378) | Hazardous alcohol use* (n=174) | Type 2 diabetes* (n=211) | Raised ALT* (any case) (n=54) |
|---|---|---|---|---|
| Age, years | 61.8 (15.0) | 54.8 (14.9) | 68.5 (11.3) | 57.0 (11.5) |
| Male, n (%) | 255 (67.5) | 138 (79.3) | 130 (61.6) | 32 (59.3) |
| Body mass index, kg/m2 | 28.53 (5.25) | 26.5 (4.2) | 30.0 (5.2) | 31.1 (5.7) |
| Obesity, n (%) | 130 (34.4) | 32 (18.4) | 100 (47.4) | 29 (53.7) |
| Hypertension, n (%) | 173 (45.8) | 47 (27.0) | 134 (63.5) | 23 (42.6) |
| Metabolic syndrome, n (%) | 117 (31.0) | 18 (10.3) | 105 (49.8) | 24 (44.4) |
| Ischaemic heart disease, n (%) | 53 (14.0) | 11 (6.3) | 44 (20.9) | 7 (13.0) |
| Type 2 diabetes, n (%) | 211 (55.8) | 20 (5.7) | 211 (100) | 27 (50.0) |
| Hazardous alcohol use, n (%) | 174 (46.0) | 174 (100) | 20 (9.5) | 18 (33.3) |
| Platelets, 109/L | 240.66 (62.45) | 240.2 (54.8) | 239.6 (65.0) | 240.2 (64.6) |
| Creatinine, µmol/L | 90.21 (23.65) | 87.7 (20.8) | 92.9 (27.9) | 85.2 (15.0) |
| Bilirubin, µmol/L | 11.97 (5.04) | 12.4 (4.4) | 11.7 (5.3) | 11.2 (6.2) |
| Albumin, g/L | 37.78 (2.92) | 38.2 (2.9) | 37.5 (3.0) | 38.0 (2.8) |
| ALT, IU/L | 28.09 (19.06) | 28.4 (21.4) | 27.2 (15.7) | 60.4 (30.6) |
| AST, IU/L | 27.91 (18.97) | 30.7 (24.6) | 25.0 (11.0) | 52.0 (39.6) |
| AST:ALT ratio | 1.09 (0.36) | 1.16 (0.35) | 1.03 (0.37) | 0.86 (0.24) |
Numerical variables are displayed as mean (SD), categorical variables are displayed as n (%).
*Patient numbers refer to patients fulfilling the single risk factor alone (see figure 2).
ALT, alanine aminotransferase, AST, aspartate aminotransferase; TE, transient elastography.